Detalles de la búsqueda
1.
CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients.
BMC Pharmacol Toxicol
; 15: 19, 2014 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-24666736
2.
A novel 11ß-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.
BMC Pharmacol Toxicol
; 15: 43, 2014 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25098735
3.
Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
BMC Pharmacol Toxicol
; 14: 28, 2013 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23692921
Resultados
1 -
3
de 3
1
Próxima >
>>